About the 2027 Conference
Mass spectrometry (MS) is an integral tool in the identification and quantification of lipids. Recent advances in MS-based technologies and methods have enabled improvements in throughput, quantitation, structural elucidation, and limits of detection. For example, innovations in ion mobility and tandem mass spectrometry (MS/MS) are allowing deeper dives into the cellular lipidome. These experiments are performed in a wide variety of fashions, including direct infusion, coupled to chromatography, and via imaging mass spectrometry. Improvements in informatics and multi-omics data integration are enabling more complete and holistic views of structures and metabolism. The scale and scope of these analyses via mass spectrometry are continually revealing new insights into disease pathology, environmental hazards, clinical applications, and pharmaceutical development. Research in lipids broadly spans fields of instrumentation, informatics, GC-MS, LC-MS, ion mobility, imaging mass spectrometry, fundamental gas-phase ion chemistry, MS/MS, molecular pathology, environmental MS, clinical MS, and drug pharmacology.
The conference will bring together experts from these diverse subfields to discuss state-of-the-art advances in instrumentation, methods, and applications. The conference will give attendees the opportunity to interact with investigators from a plethora of different research areas. It is our hope that this cross-pollination will help drive inspiration and collaboration in the field. Significant emphasis will be placed on innovations in technology and methods, but exciting applications of lipid and lipidomics research will also be discussed.